# US 2003/0228658 A1 · Melanocortin-1 receptor and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228658 A1
- Document ID: US20030228658A1
- Status: Published application
- Kind: A1
- Application number: 10/164,717
- Filed: 2002-06-10
- Published: 2003-12-11
- Earliest claimed: 2002-06-10
- Assignees: Origene Technologies, Inc.
- Inventors: Youmin Shu; Xuan Li; Anthony C. Yee; Gilbert Jay
- Web page: https://patentgrep.com/patent/US20030228658A1

## CPC

- C07K 14/47: from mammals
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to all facets of novel polynucleotides for melanocortin-1 receptors, the polypeptides they encode, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science and medicine, etc. The polynucleotides are useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to, etc., diseases and conditions especially relating to melanocortin-1, such as melanoma, pigmentation disorders and conditions, inflammation, etc. The identification of a specific genes expressed in pathways physiologically relevant to pigmentation and inflammation permits the definition of functional and disease pathways, and the delineation of targets in these pathways which are useful in diagnostic, therapeutic, and clinical applications.

## Claims

### Claim 1

An isolated polynucleotide comprising, a polynucleotide sequence coding without interruption for a human MCR-1C, or complement thereto,
said MCR-1C having 84% or more amino acid sequence identity along its entire length to the sequence comprising amino acids 1-316 of SEQ ID NO 2, and 90% or more amino acid sequence identity along its entire length to the sequence comprising from amino acids 317-398 of SEQ ID NO 2, and which has ligand-binding activity, G-protein binding activity, or cAMP production activity.

### Claim 2 (depends on 1)

An isolated polynucleotide of claim 1, said MCR-1C having 90% or more amino acid sequence identity along its entire length to the sequence comprising amino acids 1-316 of SEQ ID NO 2, and 95% or more amino acid sequence identity along its entire length to the sequence comprising from amino acids 317-398 of SEQ ID NO 2.

### Claim 3 (depends on 1)

An isolated polynucleotide of claim 1, which codes for a human MCR- 1C of SEQ ID NO 2.

### Claim 4 (depends on 1)

An isolated polynucleotide of claim 1, which is SEQ ID NO 1.

### Claim 5 (depends on 1)

An isolated polynucleotide of claim 1, which codes for a human MCR-1C of SEQ ID NO 3, 4, or 5.

### Claim 6

An isolated polynucleotide coding for a human MCR-1C polypeptide having 95% or more amino acid sequence identity along its entire length to the sequence coding for amino acids 367-398 of SEQ ID NO 2, or a fragment thereof which is specific for said human MCR-1C.

### Claim 7 (depends on 6)

An isolated polynucleotide of claim 6, wherein said fragment is effective in a polymerase chain reaction.

### Claim 8 (depends on 6)

An isolated polynucleotide of claim 6 consisting essentially of a polynucleotide sequence coding for amino acids 367-398 of SEQ ID NO 2.

### Claim 9 (depends on 1)

An isolated human MCR-1C polypeptide having an amino acid sequence of claim 1.

### Claim 10 (depends on 3)

An isolated human MCR-1C polypeptide having the amino acid sequence of claim 3.

### Claim 11 (depends on 6)

An isolated human MCR-1C polypeptide having an amino acid sequence of claim 6.

### Claim 12 (depends on 8)

An isolated human MCR-1C polypeptide having an amino acid sequence of claim 8, or a fragment thereof which is specific for a human MCR-1C.

### Claim 13 (depends on 1)

A method of detecting expression of a gene coding for human MCR- 1C, comprising,
contacting a sample comprising nucleic acid with a polynucleotide probe specific for a human MCR-1C of claim 1 under conditions effective for said probe to hybridize specifically with said human MCR-1C, and
detecting hybridization between said probe and said human MCR-1C.

### Claim 14 (depends on 14)

A method of claim 14, wherein said detecting is performed by:
Northern blot analysis, polymerase chain reaction (PCR), reverse transcriptase PCR, RACE PCR, or in situ hybridization.

### Claim 15 (depends on 1)

A method for identifying an agent that modulates the expression of a human MCR-1C gene, or the biological activity of polypeptide encoded thereby, in cells expressing said gene, comprising,
contacting cells expressing human MCR-1C of claim 1 with a test agent under conditions effective for said test agent to modulate the expression of a gene coding for said human MCR-1C, or the biological activity of a polypeptide encoded thereby, and
determining whether said test agent modulates said human MCR-1C.

### Claim 16 (depends on 15)

A method of claim 15, wherein said agent is an antisense polynucleotide which is effective to inhibit translation of said human MCR-1C.

### Claim 17

A method of detecting polymorphisms in human MCR-1C comprising:
comparing the structure of: genomic DNA comprising all or part of human MCR-1C, mRNA comprising all or part of human MCR-1C, cDNA comprising all or part of human MCR-1C, or a polypeptide comprising all or part of human MCR-1C, with the complete structure of human MCR-1C as set forth in SEQ ID NO 1.

### Claim 18 (depends on 17)

A method of claim 17, wherein said polymorphism is a nucleotide deletion, substitution, inversion, or transposition.

### Claim 19 (depends on 1)

A mammalian cell whose genome comprises a functional disruption of the human MCR-1C gene of claim 1 within a polynucleotide sequence coding for amino acid residues 367-398 of SEQ ID NO 2.

### Claim 20 (depends on 19)

A non-human, transgenic mammal comprising a cell of claim 19, which has a skin or hair pigmentation defect.

### Claim 21 (depends on 12)

An antibody which is specific-for:
an epitope selected from a human MCR-1C polypeptide of claim 12.

### Claim 22 (depends on 1)

A method of detecting a cell expressing a human MCR-1C, comprising:
contacting a sample comprising cells with a polynucleotide specific for a MCR-1C gene of claim 1 under conditions effective for said polynucleotide to hybridize specifically to said gene, and
detecting specific hybridization.

### Claim 23 (depends on 22)

A method of claim 22, wherein said detecting is performed by:
Northern blot analysis, polymerase chain reaction (PCR), reverse transcriptase PCR, RACE PCR, or in situ hybridization.

### Claim 24 (depends on 23)

A method of claim 23, wherein a pair of specific polynucleotides are utilized which are capable of amplifying a polynucleotide sequence corresponding to amino acids 367-398 of SEQ ID NO 2.

### Claim 25 (depends on 1)

A method of selecting a human MCR-1C polynucleotide or amino acid sequence from a database, comprising:
displaying, in a computer-readable medium, a polynucleotide sequence or polypeptide sequence for human MCR-1C of claim 1, or complements to the polynucleotides sequence, wherein said displayed sequences have been retrieved from said database upon selection by a user.
